A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors
NCT01283503
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
BKM120
Sponsor
Novartis Pharmaceuticals